European agency approves use of fluoxetine for children and teensBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7555.1407-a (Published 15 June 2006) Cite this as: BMJ 2006;332:1407
- Lynn Eaton
The European Medicines Agency has approved the use of fluoxetine (Prozac) for children aged 8 years or more and teenagers who have moderate to severe depression—but only where psychological therapies alone have failed.
The decision is in line with existing guidelines for England and Wales. Initially France had rejected the use of the drug in children and adolescents on the basis of unresolved concerns …
Log in using your username and password
Log in through your institution
Sign up for a free trial